Sermorelin

FDA Approved

Also known as: GRF 1-29, Geref

Growth Hormone PeptidesSubcutaneous

The first 29 amino acids of GHRH. Stimulates natural GH production and release from the pituitary. Considered a more physiological approach than exogenous GH.

Molecular Weight3357.9 Da
Half-Life (t½)~10-20 minutes
SequenceYADAIFTNSYRKVLGQLSARKLLQDIMSRQQGES

Mechanism of Action

Binds GHRH receptors on pituitary somatotrophs, stimulating GH synthesis and secretion while preserving natural pulsatile release patterns.

Dosing Protocol

200-300 mcg subcutaneous before bed. Daily use for 3-6 months.

Open peptide calculator

Reconstitution

2mg vial + 2mL BAC water = 1000 mcg/mL.

Storage

Lyophilized: -20°C. Reconstituted: 2-8°C.

Side Effects

  • Injection site irritation
  • Flushing
  • Headache
  • Dizziness

Key Research Findings

  • Restored youthful GH pulsatile patterns in aging adults
  • Improved sleep quality in GH-deficient patients
  • Increased lean body mass in clinical studies

Latest Verified Lab Report

No lab reports available for Sermorelin yet.

Community-funded testing results will appear here.

Vendor Trust Leaderboard

For Sermorelin

Trust leaderboard coming soon.

Vendor rankings based on verified lab test results.

Active Deals

Gen Peptide
10% OFF
G
Advertisement

Sponsored Ad Space

Advertise with us

Research Use Only

This information is provided for educational and research purposes only. It is not intended as medical advice. Always consult a qualified healthcare professional before using any research compounds.